Mr. Chair, this is obviously an important issue in light of the fact that when the first ministers gathered in September they actually ordered the ministers of health to put together a national pharmaceutical strategy. Part of that would be bulk purchasing, speedier drug reviews, common drug reviews and perhaps a common formulary. Those issues are very important for Canada and Canadians.
Yes, I have looked at the role of the Patented Medicine Prices Review Board and I believe that the prices for generics in Canada are relatively higher than other places. I have not been able to tackle that issue but I have been thinking about it. I think it is an important issue for our consideration. I will be considering it after I am out of the estimates and in the next few weeks.